Home › Stocks › INBX › All Fund Holders
INBX — INHIBRX BIOSCIENCES INC · All Fund Holders
Funds holding (latest): 41 · Reported value held: $632.95M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Morgan Stanley history | Q2 2026 | 1.31M | $123.94M | 0.01% | Add |
| Viking Global Investors history | Q2 2026 | 1.12M | $106.49M | 0.31% | Reduce |
| Bank of America Corp history | Q2 2026 | 841.14K | $79.70M | 0.01% | Add |
| BlackRock Inc history | Q2 2026 | 825.97K | $78.26M | 0.00% | Add |
| Vanguard Group history | Q4 2025 | 623.08K | $49.22M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 404.68K | $38.34M | 0.00% | Add |
| Capital Research Global Investors history | Q2 2026 | 363.05K | $34.40M | 0.01% | Reduce |
| Geode Capital Management history | Q2 2026 | 256.18K | $24.28M | 0.00% | Add |
| Capital World Investors history | Q2 2022 | 1.63M | $18.52M | 0.00% | Hold |
| Millennium Management history | Q2 2026 | 147.20K | $13.95M | 0.01% | Reduce |
| Northern Trust Corp history | Q2 2026 | 100.96K | $9.57M | 0.00% | Add |
| Norges Bank Investment Management history | Q2 2026 | 90.30K | $8.56M | 0.00% | Reduce |
| Citigroup Inc history | Q2 2026 | 75.72K | $7.17M | 0.00% | Add |
| Renaissance Technologies history | Q2 2026 | 62.20K | $5.89M | 0.01% | Add |
| D. E. Shaw & Co history | Q2 2026 | 45.02K | $4.27M | 0.00% | Reduce |
| Citadel Advisors history | Q2 2026 | 42.70K | $4.05M | 0.00% | Reduce |
| UBS Group AG history | Q2 2026 | 35.02K | $3.32M | 0.00% | Reduce |
| Two Sigma Investments history | Q1 2024 | 78.40K | $2.74M | 0.01% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 28.68K | $2.72M | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 26.20K | $2.48M | 0.00% | Add |
| Point72 Asset Management history | Q2 2026 | 26.01K | $2.46M | 0.00% | New |
| Wellington Management Group history | Q2 2026 | 21.42K | $2.03M | 0.00% | Reduce |
| Invesco Ltd history | Q2 2026 | 16.86K | $1.60M | 0.00% | Reduce |
| Franklin Resources history | Q2 2026 | 13.34K | $1.26M | 0.00% | Reduce |
| AQR Capital Management history | Q2 2026 | 11.25K | $1.07M | 0.00% | Add |
| Deutsche Bank AG history | Q2 2026 | 9.58K | $907.61K | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 9.56K | $906.09K | 0.00% | Add |
| Marshall Wace history | Q2 2026 | 8.80K | $833.80K | 0.00% | Reduce |
| Baron Funds history | Q2 2023 | 30.00K | $778.80K | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 5.26K | $502.33K | 0.00% | New |
| Royce & Associates history | Q4 2023 | 12.99K | $493.81K | 0.01% | New |
| Legal & General Investment Management America history | Q2 2026 | 5.14K | $486.82K | 0.00% | Add |
| Balyasny Asset Management history | Q2 2026 | 4.73K | $447.98K | 0.00% | New |
| Manulife Financial history | Q2 2026 | 4.21K | $398.52K | 0.00% | Reduce |
| Principal Global Investors history | Q1 2024 | 10.22K | $357.22K | 0.00% | Reduce |
| Janus Henderson Group history | Q1 2026 | 3.40K | $228.68K | 0.00% | New |
| Arrowstreet Capital history | Q3 2025 | 6.00K | $202.18K | 0.00% | New |
| Fidelity Management & Research (FMR) history | Q2 2026 | 1.13K | $107.49K | 0.00% | Reduce |
| Amundi US history | Q4 2022 | 465 | $11.03K | 0.00% | New |
| PNC Financial Services history | Q2 2026 | 41 | $3.88K | 0.00% | Hold |
| T. Rowe Price Associates history | Q2 2026 | 7.81K | $741 | 0.00% | Add |